Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Lupus ; 27(3): 494-500, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29251171

RESUMO

Objective Few descriptions of physical disability in childhood-onset SLE (cSLE) exist. We sought to describe disability in a large North American cohort of patients with cSLE and identify predictors of disability. Methods Sociodemographic and clinical data were obtained from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry for patients with cSLE enrolled between May 2010 and October 2014. The Childhood Health Assessment Questionnaire (CHAQ) was used to assess disability and physical functioning. Chi-square tests were used for univariate analyses, and multivariate logistic regression was used to assess predictors of disability. Results We analyzed data for 939 patients with cSLE. The median and mean CHAQ scores were 0 and 0.25, respectively, and 41% of the cohort had at least mild disability. Arthritis and higher pain scores were significantly associated with disability as compared to those without disability ( p < 0.001). In multivariate logistic regression analysis, low annual income, arthritis, and higher pain scores were associated with disability at baseline. Conclusions Disability as measured by baseline CHAQ was fairly common in cSLE patients in the CARRA Legacy Registry, and was associated with low household income, arthritis, and higher pain scores. In addition to optimal disease control, ensuring psychosocial supports and addressing pain may reduce disability in cSLE. Further study is needed of disability in cSLE.


Assuntos
Avaliação da Deficiência , Lúpus Eritematoso Sistêmico/fisiopatologia , Medição da Dor , Adolescente , Idade de Início , Canadá , Distribuição de Qui-Quadrado , Criança , Estudos de Coortes , Feminino , Humanos , Modelos Logísticos , Masculino , Análise Multivariada , Qualidade de Vida , Sistema de Registros , Índice de Gravidade de Doença , Sociedades Médicas , Estados Unidos
2.
Lupus ; 27(7): 1065-1071, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29451069

RESUMO

Background Macrophage activation syndrome (MAS) is an uncommon but serious complication of systemic lupus erythematosus (SLE). We aimed to identify factors associated with MAS among adult hospitalized SLE patients. Methods Within the Brigham and Women's Hospital (BWH) Lupus Center Registry, we identified adult SLE patients > age 17 who had been hospitalized from 1970 to 2016, with either ferritin > 5000 ng/ml during admission or "macrophage activation syndrome" or "MAS" in discharge summary. We confirmed MAS by physician diagnosis in medical record review. We matched each hospitalized SLE patient with MAS to four SLE patients hospitalized without MAS (by SLE diagnosis date ±1 year). We employed conditional logistic regression models to identify clinical factors associated with MAS among hospitalized SLE patients. Results Among 2094 patients with confirmed SLE, we identified 23 who had a hospitalization with MAS and compared them to 92 hospitalized without MAS. Cases and controls had similar age at SLE diagnosis (29.0 vs. 30.5, p = 0.60), and hospital admission (43.0 vs. 38.3, p = 0.80), proportion female (78% vs. 84%, p = 0.55), and time between SLE diagnosis and hospitalization (1971 vs. 1732 days, p = 0.84). Arthritis (OR 0.04 (95% CI 0.004-0.35)) and hydroxychloroquine use (OR 0.18 (95% CI 0.04-0.72)) on admission were associated with decreased MAS risk. Admission Systemic Lupus Erythematosus Disease Activity Index scores (30 vs. 19, p = 0.002) and lengths of stay (16 days vs. 3 days, p < 0.0001) were much higher among cases. Death during hospitalization was 19% among cases and 3% among controls ( p = 0.03). Conclusions In this case-control study of hospitalized adult SLE patients, arthritis and hydroxychloroquine use at hospital admission were associated with decreased MAS risk. Further studies are needed to validate these factors associated with lowered MAS risk.


Assuntos
Artrite/tratamento farmacológico , Hidroxicloroquina/uso terapêutico , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Síndrome de Ativação Macrofágica/prevenção & controle , Adolescente , Adulto , Estudos de Casos e Controles , Feminino , Hospitalização , Humanos , Modelos Logísticos , Lúpus Eritematoso Sistêmico/complicações , Síndrome de Ativação Macrofágica/etiologia , Masculino , Pessoa de Meia-Idade , Risco , Adulto Jovem
3.
Lupus ; 25(13): 1431-1439, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27013665

RESUMO

Objective The chronicity and severity of childhood-onset systemic lupus erythematosus (cSLE) necessitate effective transition from pediatric to adult providers. We studied transition outcomes in a cSLE cohort. Methods We identified patients at an adult lupus clinic diagnosed with SLE ≤ 18 years who had been followed by a pediatric rheumatologist. Data extracted from the first three years in adult care ("post-transition period") included: sociodemographics, depression, anxiety, SLE manifestations, SLE Disease Activity Index (SLEDAI) and Systemic Lupus International Collaborating Clinics/ACR Damage Index for SLE (SLICC) scores, non-adherence, and gaps in care (no appointments in the recommended time frame). Multivariable logistic regression analyses for predictors of: (1) time between pediatric and adult providers, (2) gaps in care, (3) unscheduled utilization (emergency department visits and admissions) (4) depression and/or anxiety were performed, as was a multivariable Poisson regression analysis for number of missed appointments. Results In 50 patients, SLEDAI scores were stable (mean 5.7 ± 5.0 at start vs. 4.7 ± 4.8 at year 3, p = 0.2), but SLICC scores increased (0.46 ± 0.84, vs. 0.78 ± 1.25, p = 0.01). Depression and anxiety increased significantly (10% vs. 26%, p = 0.02). Mean time from last pediatric to first adult provider visit was almost nine months (253 ± 392 days). Nearly 75% of patients had ≥ 1 gap in care. White race, low education level and non-adherence were significantly associated with missed appointments. Conclusion Despite moderate disease activity in this cSLE transition cohort, prolonged time between pediatric and adult providers and gaps in care in the post-transition period occurred. Anxiety and depression were frequently reported. Future work should identify methods to improve transition.


Assuntos
Ansiedade/epidemiologia , Depressão/epidemiologia , Lúpus Eritematoso Sistêmico/diagnóstico , Transição para Assistência do Adulto/estatística & dados numéricos , Adolescente , Idade de Início , Ansiedade/diagnóstico , Estudos de Coortes , Depressão/diagnóstico , Feminino , Humanos , Lúpus Eritematoso Sistêmico/psicologia , Masculino , Índice de Gravidade de Doença , Fatores Socioeconômicos , Adulto Jovem
4.
Kardiologiia ; 16(1): 16-21, 1976 Jan.
Artigo em Russo | MEDLINE | ID: mdl-5623

RESUMO

An analysis of the main causes of acute respiratory insufficiency as a frequently observed and severe complication of the early postoperative period after open-heart surgery is presented. To permit differentiated employment of respiratory resuscitation measures, subcompensated and decompensated forms of acute postoperative respiratory insufficiency were distinguished on the basis of clinical and laboratory data. The most efficient methods of treatment of this complication are described, including the employment of helium, ultrasonic inhalator, therapeutic intubation, bronchoscopy, long-term automated artificial pulmonary ventilation. A combined employment of the modified methods of respiratory resuscitation permitted to improve the course of acute respiratory insufficiency and to reduce the mortality nearly three-fold.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Complicações Pós-Operatórias , Insuficiência Respiratória/terapia , Doença Aguda , Corticosteroides/uso terapêutico , Circulação Extracorpórea , Hélio/uso terapêutico , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Humanos , Pneumopatias/etiologia , Pneumopatias/terapia , Respiração Artificial , Insuficiência Respiratória/tratamento farmacológico , Insuficiência Respiratória/etiologia , Traqueotomia , Terapia por Ultrassom
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA